• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

PILMA

Pharmaceutical Industry Labor-Management Association

GET THE LATEST
  • Home
  • Who We Are
    • About PILMA
    • Trustees
    • Partners
    • Mission Statement
  • What We Do
    • Partnership for Life
    • My Tools, Your Health
    • Saving Money, Saving Lives
    • Progress Through Collaboration
    • Continuous Partners
  • News & Resources
    • America’s Best, Saving America
    • Union Jobs Report
    • PILMA News
    • Stories
      • Union Jobs Report
      • Maryland Senator Hollen Tours IBEW Local 26
      • Smart Local 19
    • Resolutions
    • Reports
    • Video Gallery
      • Facility Tours
  • Contact Us

IBEW General President Lonnie R. Stephenson’s Letter to Secretary Raimondo on TRIPS Waiver

October 28, 2022

Read the letter here

Dear Secretary Raimondo: 

I am deeply concerned that the World Trade Organization’s recent decision  to waive intellectual property rights on Covid-19 vaccines will harm American  workers, and I fear the WTO may soon compound the damage by expanding the  waiver to Covid-19 treatments and diagnostic tools. I strongly urge your office to  protect American laborers by opposing any such expansion.  

This organization strongly endorsed President Biden’s vision of a worker centered trade agenda – one that fosters U.S. global competitiveness while  supporting American jobs.1I embrace the Administration’s agenda of strengthening  the middle class.2 

Giving away U.S. intellectual property undermines that agenda. The WTO  waiver authorizes companies in any developing country, including manufacturing  powerhouses like China and India, to make copycats of products developed in the  United States. 

It took U.S. companies and universities decades of research and billions of  dollars in investment to develop the mRNA technology behind two of the leading  Covid-19 vaccines. Giving away such prize inventions harms these U.S.  institutions, along with the skilled union workers they employ. 

Enabling foreign countries to bolster their domestic industries also makes  U.S. companies less competitive and drives down wages here, while doing nothing  to save lives. IBEW members directly benefit from robust domestic  biopharmaceutical innovation, installing and maintaining electrical infrastructure in  pharmaceutical research and manufacturing facilities around the United States.  

As workers in the electrical trades, this organization labors in fields ranging  from manufacturing to broadcasting and telecommunications. All of these, and many more, would be harmed by eroding the intellectual property rights that uphold  so much of the U.S. economy. 

I urge the administration to keep American jobs in America, as it promised,  and oppose any further weakening of intellectual property rights. 

Sincerely yours, 

Lonnie R. Stephenson 

International President 

Filed Under: News

Primary Sidebar

22.3

MILLION

Union hours supported by the pharmaceutical industry

$774

MILLION

in wages

Footer

  • Contact Us
  • Who We Are
    • About PILMA
    • Trustees
    • Partners
    • Mission Statement
  • What We Do
    • Partnership for Life
    • My Tools, Your Health
    • Saving Money, Saving Lives
    • Progress Through Collaboration
    • Continuous Partners
  • News & Resources
    • Union Jobs Reports
    • PILMA News
    • Resolutions
    • Video Gallery
    • Facility Tours

© 2025 PILMA. All Rights Reserved.
Home | Contact Us | Privacy Policy